Loading...
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.
Iqbal, J Ginsburg, O Wijeratne, T Evans, D Gareth R Evans, D Gareth R Sestak, I Narod, S
Iqbal, J
Ginsburg, O
Wijeratne, T
Evans, D Gareth R
Evans, D Gareth R
Sestak, I
Narod, S
Citations
Altmetric:
Abstract
Breast cancer prevention with tamoxifen in high-risk women is limited due to concerns of endometrial cancer and thromboembolism. We report the risk of endometrial cancer, deep vein thrombosis and pulmonary embolism in women <50 years given tamoxifen for breast cancer prevention.
Description
Date
2012-06
Publisher
Collections
Keywords
Type
Article
Citation
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. 2012, 38 (4):318-28 Cancer Treat Rev